Pacira Pharmaceuticals (NASDAQ: PCRX) was established in 2006 and is headquartered in Parsippany, New Jersey, USA. It has 503 full-time employees. Its predecessor was Pacira, Inc., and its current name was changed to Pacira Pharmaceuticals, Inc. in October 2010. , Is a professional pharmaceutical company.
Pacira Pharmaceuticals (PCRX):
Pacira Pharmaceuticals is a professional pharmaceutical company focusing on the development, manufacturing and commercial application of patented pharmaceutical products, mainly used in major hospitals and outpatient surgery centers in the United States. Pacira develops pharmaceutical products based on its proprietary technology “DepoFoam drug delivery technology”.
The main products include:
- EXPAREL, liposome injection of bupivacaine, an amide anesthetic, penetrates the surgical site and produces postoperative analgesia.
- DepoCyt(e), a liposomal preparation of cytarabine, a chemotherapeutic agent indicated for the intrathecal treatment of lymphoma meningitis, and cancer of the immune system.
- DepoMeloxicam, a long-acting non-steroidal anti-inflammatory drug for the treatment of acute postoperative pain, is still in the preclinical trial stage.
- DepoTranexamic Acid, used for the treatment of surgical hemostasis or prevention of excessive blood loss, is still in the preclinical testing stage.